Table 4 Treatment at hospital discharge.
Normal count (1707, 90.1%) | Platelet < 150 > 100 k/µl (157, 8.3%) | Platelets < 100 k/µl (30, 1.6%) | ||
---|---|---|---|---|
Treatment at discharge | DAPT (n,% of the total population) | 1581 (92.6%) | *134 (85.3%) | 27 (90.0%) |
ASA-CLOP (n,%) | 464 (29.3%) | *52 (38.8%) | *19 (70.3%) | |
ASA-PRAS (n,%) | 178 (11.2%) | 13 (9.7%) | 1 (3.7%) | |
ASA-TICA (n,%) | 939 (59.4%) | 69 (51.5%) | 7 (25.9%) | |
SAPT (N,%) | 113 (6.6%) | 23 (14.6%) | 3 (10.0%) | |
OAC (overall) (n,%) | 133 (7.8%) | *22 (14.2%) | 6 (20.0%) | |
OAC (n,%) | 2 (1.5%) | 2 (9.1%) | 0 (0%) | |
OAC + SAPT (n,%) | 24 (18.0%) | 6 (27.3%) | 0 (0%) | |
OAC + DAPT (n,%) | 107 (80.4%) | 14 (63.6%) | 6 (20.0%) | |
Statins (n,%) | 1640 (96.1%) | 154 (98.1%) | 28 (93.3%) | |
ACE-I/ARB (n,%) | 1140 (66.8%) | 100 (63.7%) | 12 (40.0%) | |
Beta block (n,%) | 1211 (70.9%) | 109 (72.7%) | 18 (60%) | |
CA (n,%) | 70 (8.2%) | 7 (4.5%) | 0 (0%) | |
Nitrates (n,%) | 138 (8.1%) | 26 (16.5%) | 2 (6.7%) | |
Diuretics (n,%) | 431 (25.2%) | 50 (31.8%) | 14 (46.7%) | |
PPI (n,%) | 1648 (96.5%) | 154 (98.1%) | 27 (90.0%) |